Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

213 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Comparison of effects of nisoldipine-extended release and amlodipine in patients with systemic hypertension and chronic stable angina pectoris.
Pepine CJ, Cooper-DeHoff RM, Weiss RJ, Koren M, Bittar N, Thadani U, Minkwitz MC, Michelson EL, Hutchinson HG; Comparative Efficacy and Safety of Nisoldipine and Amlodipine (CESNA-II) Study Investigators. Pepine CJ, et al. Among authors: michelson el. Am J Cardiol. 2003 Feb 1;91(3):274-9. doi: 10.1016/s0002-9149(02)03154-5. Am J Cardiol. 2003. PMID: 12565082 Clinical Trial.
Incidence and predictors of hyperkalemia in patients with heart failure: an analysis of the CHARM Program.
Desai AS, Swedberg K, McMurray JJ, Granger CB, Yusuf S, Young JB, Dunlap ME, Solomon SD, Hainer JW, Olofsson B, Michelson EL, Pfeffer MA; CHARM Program Investigators. Desai AS, et al. Among authors: michelson el. J Am Coll Cardiol. 2007 Nov 13;50(20):1959-66. doi: 10.1016/j.jacc.2007.07.067. Epub 2007 Oct 29. J Am Coll Cardiol. 2007. PMID: 17996561 Free article.
Clinical outcomes according to baseline blood pressure in patients with a low ejection fraction in the CHARM (Candesartan in Heart Failure: Assessment of Reduction in Mortality and Morbidity) Program.
Meredith PA, Ostergren J, Anand I, Puu M, Solomon SD, Michelson EL, Olofsson B, Granger CB, Yusuf S, Swedberg K, Pfeffer MA, McMurray JJ. Meredith PA, et al. Among authors: michelson el. J Am Coll Cardiol. 2008 Dec 9;52(24):2000-7. doi: 10.1016/j.jacc.2008.09.011. J Am Coll Cardiol. 2008. PMID: 19055992 Free article.
Atrial fibrillation and risk of clinical events in chronic heart failure with and without left ventricular systolic dysfunction: results from the Candesartan in Heart failure-Assessment of Reduction in Mortality and morbidity (CHARM) program.
Olsson LG, Swedberg K, Ducharme A, Granger CB, Michelson EL, McMurray JJ, Puu M, Yusuf S, Pfeffer MA; CHARM Investigators. Olsson LG, et al. Among authors: michelson el. J Am Coll Cardiol. 2006 May 16;47(10):1997-2004. doi: 10.1016/j.jacc.2006.01.060. Epub 2006 Apr 27. J Am Coll Cardiol. 2006. PMID: 16697316 Free article. Clinical Trial.
The incidence of bradyarrhythmias and clinical bradyarrhythmic events in patients with acute coronary syndromes treated with ticagrelor or clopidogrel in the PLATO (Platelet Inhibition and Patient Outcomes) trial: results of the continuous electrocardiographic assessment substudy.
Scirica BM, Cannon CP, Emanuelsson H, Michelson EL, Harrington RA, Husted S, James S, Katus H, Pais P, Raev D, Spinar J, Steg PG, Storey RF, Wallentin L; PLATO Investigators. Scirica BM, et al. Among authors: michelson el. J Am Coll Cardiol. 2011 May 10;57(19):1908-16. doi: 10.1016/j.jacc.2010.11.056. J Am Coll Cardiol. 2011. PMID: 21545948 Free article. Clinical Trial.
Association of heart rate and outcomes in a broad spectrum of patients with chronic heart failure: results from the CHARM (Candesartan in Heart Failure: Assessment of Reduction in Mortality and morbidity) program.
Castagno D, Skali H, Takeuchi M, Swedberg K, Yusuf S, Granger CB, Michelson EL, Pfeffer MA, McMurray JJ, Solomon SD; CHARM Investigators. Castagno D, et al. Among authors: michelson el. J Am Coll Cardiol. 2012 May 15;59(20):1785-95. doi: 10.1016/j.jacc.2011.12.044. J Am Coll Cardiol. 2012. PMID: 22575317 Free article. Clinical Trial.
Trial of preventing hypertension: design and 2-year progress report.
Julius S, Nesbitt S, Egan B, Kaciroti N, Schork MA, Grozinski M, Michelson E; TROPHY study group. Julius S, et al. Hypertension. 2004 Aug;44(2):146-51. doi: 10.1161/01.HYP.0000130174.70055.ca. Epub 2004 Jul 6. Hypertension. 2004. PMID: 15238567 Clinical Trial.
Randomized trial of candesartan cilexetil in the treatment of patients with congestive heart failure and a history of intolerance to angiotensin-converting enzyme inhibitors.
Granger CB, Ertl G, Kuch J, Maggioni AP, McMurray J, Rouleau JL, Stevenson LW, Swedberg K, Young J, Yusuf S, Califf RM, Bart BA, Held P, Michelson EL, Sellers MA, Ohlin G, Sparapani R, Pfeffer MA. Granger CB, et al. Among authors: michelson el. Am Heart J. 2000 Apr;139(4):609-17. doi: 10.1016/s0002-8703(00)90037-1. Am Heart J. 2000. PMID: 10740141 Clinical Trial.
213 results